SEATTLE, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (SANA) (“Sana”), a company focused on changing the possible for patients through engineered cells, today announced that it has ...
REHOVOT, Israel, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (PPBT), a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug ...
The net proceeds from these warrant exercises, along with the net proceeds of approximately $141 million from the recent public offering that closed on February 20, 2026, and its existing cash and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results